Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated)
- Licence status
- Active substances
- A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26) [Victoria lineage], B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE)
- Dosage Form
- Suspension for injection in pre-filled syringe
- Licence number
- PA1077/134/001
- Licence holder
- GlaxoSmithKline (Ireland) Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J07BB Influenza vaccines, J07BB02 influenza, inactivated, split virus or surface antigen
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Batches of vaccine marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 01/06/2018